Insulet Corporation - Common Stock (NQ:PODD)

PODD Q3 2026 deep dive: international strength and innovation pipeline set stage for moderate growth

S&P 500 Top Movers: Nov. 6, 2026 Gainers and Losers ↗

November 06, 2026

Via Chartmill

Performance

52-Week Range 57.9% below 52-week high

149.29

126.4052W Low 354.8852W High

1 Week 4.1% below 1-week high

143.281W Low 155.601W High

Insulet Corporation - Common Stock (PODD) traded between $126.40 and $354.88 over the past 52 weeks and last traded at $149.29, 57.9% below its 52-week high. Over the past week it ranged between $143.28 and $155.60.

Past 12 Months

+1.9%

+8.1%

+1.9%

+0.4%

-47.2%

-55.7%

1W +$2.78

1M +$11.16

3M +$2.85

6M +$0.61

YTD -$133.63

1Y -$187.55

PODD was -55.7% over the past year, +0.4% over six months, -47.2% year to date, +1.9% in the last week.

12 Months vs Market

PODD

-55.7%

DIA

+8.2%

SPY

+10.8%

QQQ

+10.8%

IWM

+14.3%

Over the past 12 months PODD returned -55.7% versus DIA (Dow) +8.2%, SPY (S&P 500) +10.8%, QQQ (Nasdaq 100) +10.8% and IWM (Russell 2000) +14.3%.

Volume & Liquidity 0.47× 3-mo avg

Today 745,765 3-mo avg 1.6M

1.2M

1.4M

1.6M

YTD

1.4M

1.3M

PODD most recently traded 745,765 shares against a 3-month average daily volume of 1.6M.

More News

S&P 500 Top Movers: Gainers and Losers on Nov. 6, 2026 ↗

November 06, 2026

Via Chartmill

S&P 500 Gap-Down Stocks in Today's Session ↗

November 06, 2026

Via Chartmill

Insulet (NASDAQ:PODD): A Growth-at-a-Reasonable-Price Case With Strong Expansion ↗

October 22, 2026

Via Chartmill

Insulet (NASDAQ:PODD) Offers Affordable Growth With Strong Fundamentals ↗

September 30, 2026

Via Chartmill

November 05, 2026

What Insulet (PODD) Said on Its Q3 Earnings Call ↗

November 04, 2026

Via MarketBeat

Insulet (PODD) Q3 2026 Earnings Call Transcript ↗

November 04, 2026

Via The Motley Fool

Insulet (NASDAQ:PODD) posts better-than-expected sales in Q3 2026, stock soars

November 04, 2026

Insulet Reports Third Quarter 2026 Results

November 04, 2026

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

November 03, 2026

Insulet (PODD) Q3 earnings: what to expect

November 02, 2026

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); and Planet Fitness, Inc. (NYSE: PLNT): Grabar Law Office is Investigating Claims on Your Behalf

October 30, 2026

From Grabar Law Office

Via GlobeNewswire

S&P 500 Postmarket Decliners After Tuesday's Close ↗

October 27, 2026

Via Chartmill

2 Profitable Stocks to Keep an Eye On and 1 We Question

October 19, 2026

2 of Wall Street’s Favorite Stocks to Target This Week and 1 We Ignore

October 16, 2026

Insulet Announces Omnipod Discover Now Available in U.S.

October 12, 2026

Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); Better Home & Finance Holding Company (NASDAQ: BETR); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your

October 01, 2026

From Grabar Law Office

Via GlobeNewswire

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

October 01, 2026

2 Safe-and-Steady Stocks to Consider Right Now and 1 Facing Challenges

October 01, 2026

Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum ↗

September 25, 2026

Via MarketBeat

2 Healthcare Stocks with Impressive Fundamentals and 1 Facing Challenges

September 25, 2026

Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

September 18, 2026